Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for Liver Function Recovery After Hepatectomy
NCT04221672Phase 3Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Nov 2019
- Primary completion
- Dec 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of terlipressin in Portal Hypertension (PH), sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
terlipressin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT04221672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04221672.